News & Articles

Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a human cell component involved in viral replication

The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process

Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity

The research brings a deeper understanding about how fructose could be linked to diabetes and obesity

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA

Companion diagnostic can help guide treatment decisions in cases of NSCLC

Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System

The design may enable miniature zoom lenses for drones, cellphones, or night-vision goggles

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

New events to provide valuable content and practical solutions to boost experimental success within chemistry labs

The combined offering is designed to provide researchers with high quality tools to diagnose cancer and selected genetic disease

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Researchers have developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients

Increasing Portuguese market presence by enhancing sales and after-sales support networks

RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein